Approval of Unaudited Financial Results for the quarter and half-year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 2.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Tyche Industries' Board approved unaudited results for Q2 and H1 FY26. Revenue from operations fell about 20% YoY to Rs 2,885.94 lakh in H1 FY26 (from Rs 3,605.57 lakh in H1 FY25), driven entirely by its single APIS segment, where exports dominate (Rs 2,444.25 lakh vs domestic Rs 241.68 lakh). Net profit after tax dropped roughly 41% YoY to Rs 395.43 lakh (from Rs 672.01 lakh), and EPS fell to Rs 3.86 from Rs 6.56. Sequentially, Q2 revenue rose about 27% QoQ but PAT slipped to Rs 152.30 lakh from Rs 243.13 lakh. The statutory auditor (P.S.N. Ravishanker & Associates) issued a clean limited review report with no qualifications.
Sharp YoY decline in both revenue and profits, with margins visibly compressed, signals weakening demand or pricing pressure in the company's APIS export business. Shareholders may view this negatively in the near term despite a clean auditor report and positive operating cash flow.